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Introduction
Triazole antifungals are commonly used in the treatment
of candidiasis. Fluconazole (FCZ) is one of the most fre-
quently prescribed therapy for vaginal fungal infections.
Rarely, FCZ has been shown to cause fixed drug erup-
tions (FDE).
Case presentation
This is a report of FCZ-induced FDE in a 31-year-old
Caucasian woman with recurrent vaginal candidiasis. On
4 consecutive occasions she tried treatment with oral
150mg FCZ and each time skin lesions occurred in the
same spots with progressive severity, lasting about
10 days, resulting in a hyperpigmentation, causing suffer-
ing and poor self-confidence. Detailed history revealed
that the first time she noticed the eruption, there was a
single, erythematous plaque on the forehead. On the sec-
ond and third occasions, this same spot reappeared, but
this time accompanied by 2 more similar lesions on both
cheeks. The patient was told that this was “mild allergy”
and not advised to seek specialized help. She was sent to
our university clinic on the 4th occasion when she took a
single dose of oral 150mg FCZ (different brand name).
The patient had 3 nummular, erythematous plaques: 1
on the forehead (15mm D), 1 in the left and 1 in the
right zygomatic areas (15 and 20mm D, respectively).
Also, a medium edema in the middle part of her upper
lip was present for the first time. The eruptions were
characterized by pruritus, stinging and erythema, gradu-
ally increasing in intensity from 30min post-ingestion
(PI). The edema of the upper lip was slightly painful and
occurred 6h PI. We treated the patient with Methylpred-
nisolone 60mg (1 day) and gave her Levocetirizine 5mg
for symptomatic relief; as this latter dose did not seem
sufficient, we doubled it and this completely suppressed
her symptoms. Topical Mometasone was added to the
treatment on Day 2. Skin lesions resolved almost comple-
tely on Day 7, leaving mild hyperpigmentations. The
edema of the lip resolved on Day 3 with no sequel. Histo-
logic evaluation, oral and topical provocation tests with
FCZ were not performed because of the delicate facial
site of manifestation. Oral provocation test with Itracona-
zole 100mg was performed and showed to be negative.
Conclusion
FDE induced by FCZ is not a common occurrence.
When it does occur, it can be easily overlooked and
misdiagnosed. We rejected cross reactivity with Itraco-
nazole, showing this drug is a viable alternative to FCZ.
Oral Levocetirizine at a higher than usual dose helped
relieve the subjective symptoms.
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